Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001332571 | SCV001524941 | uncertain significance | Autosomal dominant nocturnal frontal lobe epilepsy 1 | 2020-04-14 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV002384445 | SCV002693332 | uncertain significance | Inborn genetic diseases | 2020-03-27 | criteria provided, single submitter | clinical testing | The p.W343C variant (also known as c.1029G>C), located in coding exon 5 of the CHRNA4 gene, results from a G to C substitution at nucleotide position 1029. The tryptophan at codon 343 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |